Metraipolis › archive › dc_e859e63cf100

Clinical and economic benefits of seasonal COVID-19 vaccination in Germany: results from the ROUTINE-COV19 Study, September 2022 to March 2024 — Europe PMC PMID:42141891

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42141891
DOI
10.2807/1560-7917.es.2026.31.15.2500672
License (as archived)
solo-consultazione
Archived
2026-11-03T12:33:28.255Z
SHA-256 of the archived text
48455838895cb8184ab0fb63dae6b387afb27db99d0b70b3436a1bdcbf5dc4e7
Stable URL of this page
https://metraipolis.com/documento/dc_e859e63cf100

How to cite

Clinical and economic benefits of seasonal COVID-19 vaccination in Germany: results from the ROUTINE-COV19 Study, September 2022 to March 2024 — Europe PMC PMID:42141891 — Europe PMC (en), https://europepmc.org/article/MED/42141891 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e859e63cf100 (Metraipolis archive dc_e859e63cf100, sha256 48455838895cb8184ab0fb63dae6b387afb27db99d0b70b3436a1bdcbf5dc4e7)
BibTeX
@misc{dce859e63cf100,
  title = {Clinical and economic benefits of seasonal COVID-19 vaccination in Germany: results from the ROUTINE-COV19 Study, September 2022 to March 2024 — Europe PMC PMID:42141891},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42141891},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e859e63cf100; sha256 48455838895cb8184ab0fb63dae6b387afb27db99d0b70b3436a1bdcbf5dc4e7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42141891. Agents can read the archived copy with the MCP tool read_document.